Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sevoflurane in Subarachnoid Haemorrhage
NCT02946437Phase 2Withdrawn
- Sponsor
- University of Zurich
- Start
- Nov 2015
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sevoflurane in subarachnoid hemorrhage (SAH), sponsored by University of Zurich. Planned start Nov 2015; status: withdrawn.
02
Drugs
sevoflurane
03
Conditions
subarachnoid hemorrhage (SAH)
Beyond the preview
Go deeper on NCT02946437.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02946437.